[1]李福刚,雷 蕾,石晓强,等.血清淀粉样蛋白A(SAA)水平检测在临床实验诊断及健康监测中的应用[J].现代检验医学杂志,2019,34(03):1-5.[doi:10.3969/j.issn.1671-7414.2019.03.001]
 LI Fu-Gang,LEI Lei,SHI Xiao-qiang,et al.Serum Amyloid A(SAA)Test in Clinical Diagnosis and Health Monitoring[J].Journal of Modern Laboratory Medicine,2019,34(03):1-5.[doi:10.3969/j.issn.1671-7414.2019.03.001]
点击复制

血清淀粉样蛋白A(SAA)水平检测在临床实验诊断及健康监测中的应用()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第34卷
期数:
2019年03期
页码:
1-5
栏目:
述评
出版日期:
2019-06-20

文章信息/Info

Title:
Serum Amyloid A(SAA)Test in Clinical Diagnosis and Health Monitoring
文章编号:
1671-7414(2019)03-001-05
作者:
李福刚1雷 蕾2石晓强1杨 晶1王 鼎1王东旭1尚 勇1顾敏晔1蒋瑾瑾2薛汉阳3
(1.上海奥普生物医药有限公司,上海即时检测医学工程技术研究中心,上海 201201; 2.海军军医大学附属长海医院,上海 200433; 3.中国人民解放军第八五医院,上海 200000)
Author(s):
LI Fu-Gang1LEI Lei2SHI Xiao-qiang1YANG Jing1WANG Ding1WANG Dong-xu1SHANG Yong1GU Min-ye1JIANG Jin-jin2XUE Han-yang3
(1.Shanghai Upper Biotech Pharma Co.Ltd.,Shanghai POCT Medical Engineering TechnologyResearch Center,Shanghai 201201,China; 2.Changhai Hosptial Affiliated to the NavalMedical University,Shanghai 200433,China; 3.No.85 Hosptial of PLA,Shanghai 200000,China)
关键词:
血清淀粉样蛋白A 临床诊断 健康监测
分类号:
R446.11
DOI:
10.3969/j.issn.1671-7414.2019.03.001
文献标志码:
A
摘要:
血清淀粉样蛋白A(serum amyloid,SAA)是组织淀粉样蛋白A的前体物质,是急性时相反应蛋白之一。同时,SAA也可能参与类风湿关节炎、动脉粥样硬化等慢性炎症性疾病的发病机制,SAA对感染、心血管疾病、肿瘤、结核、淀粉样病变、移植排异等多种疾病的辅助诊断和健康监测均有重要意义。该文就SAA在临床试验诊断及健康监测中的临床应用进行了评述。
Abstract:
Serum amyloid(SAA)is a precursor of tissue amyloid A and is one of the acute phase reactive proteins. At the same time, SAA may also be involved in the pathogenesis of chronic inflammatory diseases such asrheumatoid arthritis and atherosclerosis.The significance of SAA is very important both in diagnosis and health monitoring for various diseases such as infection,cardiovascular disease,tumor,tuberculosis,amyloidosis,and transplant rejection.This article reviews the clinical application of SAA in clinical trialdiagnosis and health monitoring.

参考文献/References:

[1] 陈长强,顾志冬,樊绮诗.血清淀粉样蛋白A在疾病应用中的研究进展[J].检验医学,2012,27(9):776-779. CHEN Changqiang,GU Zhidong,FAN QiShi.Research progress of serum amyloid A in the application of disease[J].Laboratory Medicine,2012,27(9):776-779.
[2] SACK G.Serum amyloid A-a review[J].Molecular Medicine,2018,24(1):46.
[3] 焦荣红,沈海涛,王淑芬,等.类风湿关节炎患者血清淀粉样蛋白A和C反应蛋白水平与疾病活动度的关系[J].现代检验医学杂志,2019,34(1):55-57,61. JIAO Ronghong,SHEN Haitao,WANG Shufen,et al.Relationship betweenserum amyloid A and C-reactive protein in patients with rheumatoid arthritis and activity of disease[J].Journal of Modern Laboratory Medicine,2019,34(1):55-57,61.
[4] HWANG Y G,BALASUBRAMANI G K,METES I D,et al.Differential response ofserum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker[J].Arthritis Research & Therapy,2016,18(1):108.
[5] THOMPSON J C,JAYNE C,THOMPSON J,et al.A brief elevation of serum amyloid A is sufficient to increase atherosclerosis[J].Journal of Lipid Research,2015,56(2):286-293.
[6] YE R D,SUN Lei.Emerging functions of serum amyloid A in inflammation[J].Journal of Leukocyte Biology,2015,98(6):923-929.
[7] ZEWINGER S,DRECHSLER C,KLEBER M E,et al.Serum amyloid A:high-density lipoproteins interaction and cardiovascular risk[J].European Heart Journal,2015,36(43):3007-3016.
[8] BATIREL A.Predictive values of serum amyloid-A and CRP for infection infebrile neutropenic cancer patients[J].Journal of Microbiology & InfectiousDiseases,2014,4(4):128-135.
[9] REN Yanjie,WANG He,LU Donghao,et al.Expression of serum amyloid A inuterine cervical cancer[J].Diagnostic Pathology,2014,9(1):16.
[10] WAN-IBRAHIM W I,ASHRAFZADEH A,SINGH V A,et al.Contrasting increased levels of serum amyloid A in patients with three different bone sarcomas:An indicator of tumour malignancy?[J].Electrophresis,2016,37(17/18):2328-2337.
[11] GOLETTI D,PETRUCCIOLI E,JOOSTEN S A,et al.Tuberculosis biomarkers:from diagnosis to protection[J].Infectious Disease Reports,2016,8(2):6568.
[12] LU Jinghua,YU Yadong,ZHU I,et al.Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis[J].Proc Natl Acad Sci USA,2014,111(14):5189-5194.
[13] O'REILLY S,CANT R,CIECHOMSKA M,et al.Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2,interleukin-1 receptor-associated kinase 4 and nuclear factor-κB[J].Immunology,2015,143(3):331-340.
[14] 杨红玲,郑磊,周才,等.胶体金渗滤法检测血清淀粉样蛋白A方法评价及其在儿童感染性疾病诊断中的应用[J].中华检验医学杂志,2014,37(11):836-841.YANG Hongling,ZHENG Lei,ZHOU Cai,et al.The evaluation of dot immunogold filtration method in detection of serum SAA and its clinical value of diagnosing the infectious diseases of children[J].Chin J Lab Med,2014,37(11):836-841.
[15] 戴晓勇,陈永珍,华玮,等.血清淀粉样蛋白A,C反应蛋白和降钙素原在脓毒性休克中的应用价值与相关性分析[J].现代检验医学杂志,2019,34(1):47-50.DAI Xiaoyong,CHEN Yongzhen,HUA Wei,et al.Application and correlation analysis of serum amylase A,C-reactive protein and procalcitonin in septic shock[J].Journal of Modern Laboratory Medicine,2019,34(1):47-50.
[16] 罗强,刘振杰,徐宁,等.联合检测SAA,hs-CRP,PCT和WBC在广东地区不同年龄人群感染患者诊断价值的多中心分析[J].现代检验医学杂志,2015,30(4):39-42.LUO Qiang,LIU Zhenjie,XU Ning,et al.Multice-nter study on serum amyloid A protein,high-sensitivity C-reactive protein and procalcitonin in combining diagnosis of infection in different population from Guangdong[J].Journal of Modern Laboratory Medicine,2015,30(4):39-42.
[17] 托马斯.临床实验诊断学[M].吕元,朱汉民,沈霞,译.上海.上海科技出版社,2004. THOMAS L.Clinical Laboratory Diagnostics[J].L(¨overU)Yuan,ZHUHanmin,SHEN Xia,Interpret.Shanghai:Shanghai Science and Technology Publishing House,2004.
[18] 田月如,李巍,叶志成,等.血清淀粉样蛋白A 和C 反应蛋白检测在儿童感染性疾病诊断中的应用[J].检验医学,2017,32(5),382-385.TIAN Yueru,LI Wei,YE Zhicheng,et al.Determinations of serum amyloid Aand C-reactive protein for the diagnosis of infectious diseases in children[J].Laboratory Medicine,2017,32(5),382-385.
[19] ABBAS M H,CHOUDHRY M N,HAMZA N,et al.Admission levels of serum amyloid A and procalcitonin are more predictive of the diagnosis of acute appendicitis compared with C-reactive protein[J].Surgical Laparoscopy Endoscopy & Percutaneous Techniques,2014,24(6):488-494.
[20] 蒋瑾瑾.“新三大常规”组合检测的临床意义[EB/OL].(2017-06-27).http://www.sohu.com/a/152604742_99903472.JIANG Jinjin.Clinical significance of “new three ro-utine” combined letection[EB/OL].(2017-06-27).http://www.sohu.com/a/152604742_99903472.
[21] TODOROV I,GOSPODINOVA M,BOCHEVA Y,et al.Serum amyloid A protein in the course of infectious mononucleosis[J].Therapeutic Advances Infectious Disease,2019,6:1-6.
[22] 2017 ACR/ARHP Anivual Meeting Abstract Supplement.Serum amyloid A aggravates rheumatoid arthritis by activating NFAT5-mediated migration of macrophages[C].Arthritic Rheumatol,2017,69(suppl 10):1-4426.
[23] TARGOSKA-STOPNIAK B, MAJDAN M.Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis[J].Mediators of Inflammation,2014,2014:793628.
[24] SHEN Chen,SUN Xuguo,LIU Na,et al.Increased serum amyloid A and its association with autoantibodies,acute phase reactants and disease activity in patients with rheumatoid arthritis[J].Molecular Medicine Reports,2015,11(2):1528-1534.
[25] KNEBEL F H,UNO M,GALATRO T F,et al.Serum amyloid A1 is upregulated in human glioblastoma[J].Journal of Neuro-Oncology,2017,132(3):383-391.
[26] ZHANG Guojun,SUN Xudong,L(¨overU)Hong,et al.Serum amyloid A:A newpotential serum marker correlated with the stage of breast cancer[J].Oncology Letters,2012,3(4):940-944.
[27] BIAOXUE R,LIU Huahua,GUO Wenlong,et al.Increased serum amyloid A aspotential diagnostic marker for lung cancer:a meta-analysis based on nine studies[J].BMC Cancer,2016,16(1):836.
[28] RUIPING Z.Inflammatory biomarkers of coronary heart disease[J].Frontiers in Bioscience,2017,22(3):504-515.
[29] ISHIHARA S,TADA Y,KAWASHIMA K,et al.Serum amyloid A level correlatedwith endoscopic findings in patients with Crohn's disease-possible biomarkerfor evaluating mucosal healing[J].Digestive and Liver Disease,2017:50(6):553-558.
[30] SATO M,OHKAWA R,YOSHIMOTO A,et al.Effects of serum amyloid A on thestructure and antioxidant ability of high-density lipoprotein[J].BioscienceReports,2016,36(4):e00369-e00369.
[31] ANDERBERG R J,MEEK R L,HUDKINS K L,et al.Serum amyloid A and inflammation in diabetic kidney disease and podocytes[J].Laboratory Investigation,2015,95(3):250-262.

相似文献/References:

[1]罗 强,刘振杰,徐 宁,等.联合检测SAA,hs-CRP,PCT和WBC在广东地区不同年龄人群感染患者诊断价值的多中心分析[J].现代检验医学杂志,2015,30(04):39.[doi:10.3969/j.issn.1671-7414.2015.04.010]
 LUO Qiang,LIU Zhen-jie,XU Ning,et al.Multicenter Study on Serum Amyloid A Protein, High-Sensitivity C-Reactive Protein and Procalcitonin in Combining Diagnosis of Infection in Different Population from Guangdong[J].Journal of Modern Laboratory Medicine,2015,30(03):39.[doi:10.3969/j.issn.1671-7414.2015.04.010]
[2]戴晓勇,陈永珍,华玮,等.血清淀粉样蛋白A,C反应蛋白和降钙素原在脓毒性休克中的应用价值与相关性分析[J].现代检验医学杂志,2019,34(01):47.[doi:10.3969/j.issn.1671-7414.2019.01.012]
 DAI Xiao-yong,CHEN Yong-zhen,HUA Wei,et al.Application and Correlation Analysis of Serum Amylase A, C-reactive Protein and Procalcitonin in Septic Shock[J].Journal of Modern Laboratory Medicine,2019,34(03):47.[doi:10.3969/j.issn.1671-7414.2019.01.012]
[3]焦荣红a,沈海涛,王淑芬a,等.类风湿关节炎患者血清淀粉样蛋白A和C反应蛋白水平与疾病活动度的关系[J].现代检验医学杂志,2019,34(01):55.[doi:10.3969/j.issn.1671-7414.2019.01.014]
 JIAO Rong-honga,SHEN Hai-tao,WANG Shu-fe na,et al.Relationship between Serum Amyloid A and C-reactive Protein in Patients with Rheumatoid Arthritis and Activity of Disease[J].Journal of Modern Laboratory Medicine,2019,34(03):55.[doi:10.3969/j.issn.1671-7414.2019.01.014]
[4]宋事竑,曾而明.血清淀粉样蛋白A 与血管新生最新研究进展[J].现代检验医学杂志,2020,35(02):157.[doi:10.3969/j.issn.1671-7414.2020.02.043]
 SONG Shi-hong,ZENG Er-ming.Recent Advances in Serum Amyloid A and Angiogenesis[J].Journal of Modern Laboratory Medicine,2020,35(03):157.[doi:10.3969/j.issn.1671-7414.2020.02.043]

备注/Memo

备注/Memo:
基金项目:智慧即时检测(iPOCT)医学平台临床示范应用研究(17DZ1930300); 上海市科委科技创新产学研医项目。 作者简介:李福刚(1975-),男,博士,高级工程师,从事智慧即时检测产品的研究、开发与推广,E-mail:lfg@poct.cn。 收稿日期:2019-04-01 修回日期:2019-04-24
更新日期/Last Update: 2019-06-20